Literature DB >> 15309253

[Course and therapy of an invasive aspergilloma of the skull base in a non-immunocompromised patient].

S Wenzel1, C Sagowski, W Kehrl, F U Metternich.   

Abstract

Fulminant-invasive sinus aspergillosis affects immunocompromised patients and is usually lethal because of intracranial complications. Chronic-invasive and non-invasive types occur in non-immunocompromised patients. In these cases, intracranial extension is possible and life-threatening. The effective management of sinus aspergillosis requires early diagnosis by CT and histological classification, surgery, and if necessary, chemotherapy or steroids in case of allergy. Here we report a successfully treated case in a 29-year-old non-immunocompromised patient with chronic-invasive sinus aspergillosis. He presented a recurrent sphenoid sinus aspergillosis with destruction of the clivus and ophthalmoplegia. Diagnostic and therapeutic procedures are described.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15309253     DOI: 10.1007/s00106-003-0949-0

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  15 in total

1.  Successful treatment of an invasive aspergillosis of the skull base and paranasal sinuses with liposomal amphotericin B and itraconazole.

Authors:  M Streppel; G Bachmann; G Arnold; M Damm; E Stennert
Journal:  Ann Otol Rhinol Laryngol       Date:  1999-02       Impact factor: 1.547

Review 2.  Fungal sinusitis.

Authors:  R D deShazo; K Chapin; R E Swain
Journal:  N Engl J Med       Date:  1997-07-24       Impact factor: 91.245

3.  [Formation of roentgen dense structures in aspergillus mycoses of the paranasal sinuses].

Authors:  H Stammberger
Journal:  HNO       Date:  1985-02       Impact factor: 1.284

4.  Transnasal endoscopic surgery of sphenoid sinus aspergillosis.

Authors:  W S Lin; H Y Hung
Journal:  J Laryngol Otol       Date:  1993-09       Impact factor: 1.469

5.  Invasive aspergilloma of the skull base.

Authors:  D J Breen; A G Clifton; P Wilkins; D Uttley; G Westmore
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

6.  Development of molecular methods for identification of Schizophyllum commune from clinical samples.

Authors:  W Buzina; D Lang-Loidolt; H Braun; K Freudenschuss; H Stammberger
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

7.  [Features of aspergillosis in ENT. Histopathology of fungal infections of the paranasal sinuses caused by Aspergillus fumigatus (author's transl)].

Authors:  H Stammberger; R Jakse
Journal:  HNO       Date:  1982-03       Impact factor: 1.284

8.  Allergic Aspergillus sinusitis: a newly recognized form of sinusitis.

Authors:  A L Katzenstein; S R Sale; P A Greenberger
Journal:  J Allergy Clin Immunol       Date:  1983-07       Impact factor: 10.793

9.  Destructive noninvasive paranasal sinus aspergillosis: component of a spectrum of disease.

Authors:  J M Rowe-Jones; V Moore-Gillon
Journal:  J Otolaryngol       Date:  1994-04

Review 10.  Fungal sinusitis: an update.

Authors:  J F Morpeth; N T Rupp; W K Dolen; J P Bent; F A Kuhn
Journal:  Ann Allergy Asthma Immunol       Date:  1996-02       Impact factor: 6.347

View more
  2 in total

1.  [Allergic fungal sinusitis, fungus ball and invasive sinonasal mycosis - three fungal-related diseases].

Authors:  Oliver Driemel; Christina Wagner; Susann Hurrass; Urs Müller-Richter; Thomas Kühnel; Torsten Eugen Reichert; Hartwig Kosmehl
Journal:  Mund Kiefer Gesichtschir       Date:  2007-08

2.  [Invasive aspergillosis of the skull base with orbit infiltration].

Authors:  G Götze; M Bloching; M Hainz; S Knipping
Journal:  HNO       Date:  2007-07       Impact factor: 1.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.